adenosine monophosphate has been researched along with phenylephrine hydrochloride in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Boucher, RC; Burch, LH; Hirsh, AJ; Picher, M; Spychala, J | 1 |
Barnes, ML; Lipworth, BJ; Meldrum, K; Nair, A; Vaidyanathan, S | 1 |
Brun, P; Constant, S; Dubois, J; Dulière, V; Errazuriz-Cerda, E; Fouret, J; Gaymard, A; Julien, T; Lescure, FX; Lina, B; Padey, B; Pizzorno, A; Poissy, J; Rosa-Calatrava, M; Terrier, O; Traversier, A; Trouillet-Assant, S; Yazdanpanah, Y | 1 |
Ejima, K; Fujita, Y; Iwami, S; Iwanami, S; Kim, KS; Kuba, K; Miyazaki, T; Oda, T | 1 |
1 trial(s) available for adenosine monophosphate and phenylephrine hydrochloride
Article | Year |
---|---|
Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis.
Topics: Adenosine Monophosphate; Adult; Aged; Allergens; Area Under Curve; Cetirizine; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nasal Provocation Tests; Nose; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Young Adult | 2009 |
3 other study(ies) available for adenosine monophosphate and phenylephrine hydrochloride
Article | Year |
---|---|
Ecto 5'-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways.
Topics: 5'-Nucleotidase; Adenosine Monophosphate; Alkaline Phosphatase; Base Sequence; Bronchi; Cell Membrane; Cells, Cultured; DNA Primers; Humans; Hydrolysis; Kinetics; Nose; Respiratory Mucosa; Substrate Specificity | 2003 |
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.
Topics: Adenosine Monophosphate; Airway Remodeling; Alanine; Animals; Antiviral Agents; Bronchi; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Diltiazem; Drug Synergism; Humans; Immunity, Innate; Models, Biological; Nose; Respiratory Mucosa; SARS-CoV-2; Vero Cells | 2020 |
Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Lung; Macaca mulatta; Models, Theoretical; Nose; Pharynx; SARS-CoV-2; Time Factors; Viral Load; Virus Replication; Virus Shedding | 2021 |